Aetna Inc. (AET) Shares Sold by Adirondack Trust Co.
Adirondack Trust Co. lowered its position in shares of Aetna Inc. (NYSE:AET) by 4.0% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 2,303 shares of the company’s stock after selling 95 shares during the period. Adirondack Trust Co.’s holdings in Aetna were worth $350,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in the stock. Guardian Life Insurance Co. of America boosted its stake in Aetna by 0.7% in the first quarter. Guardian Life Insurance Co. of America now owns 1,353 shares of the company’s stock valued at $173,000 after buying an additional 9 shares in the last quarter. Concert Wealth Management Inc. boosted its stake in Aetna by 0.4% in the first quarter. Concert Wealth Management Inc. now owns 3,262 shares of the company’s stock valued at $405,000 after buying an additional 14 shares in the last quarter. CAPROCK Group Inc. boosted its stake in Aetna by 0.9% in the first quarter. CAPROCK Group Inc. now owns 2,824 shares of the company’s stock valued at $360,000 after buying an additional 25 shares in the last quarter. Rehmann Capital Advisory Group boosted its stake in Aetna by 1.1% in the first quarter. Rehmann Capital Advisory Group now owns 2,335 shares of the company’s stock valued at $298,000 after buying an additional 25 shares in the last quarter. Finally, Geneva Advisors LLC boosted its stake in Aetna by 1.0% in the first quarter. Geneva Advisors LLC now owns 2,588 shares of the company’s stock valued at $330,000 after buying an additional 25 shares in the last quarter. 91.73% of the stock is owned by institutional investors and hedge funds.
Shares of Aetna Inc. (AET) opened at 152.15 on Friday. The firm has a market capitalization of $50.53 billion, a PE ratio of 33.77 and a beta of 0.54. Aetna Inc. has a 1-year low of $104.59 and a 1-year high of $161.69. The firm has a 50-day moving average price of $154.26 and a 200-day moving average price of $139.02.
Aetna (NYSE:AET) last issued its earnings results on Thursday, August 3rd. The company reported $3.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.34 by $1.08. The business had revenue of $15.52 billion for the quarter, compared to analyst estimates of $15.34 billion. Aetna had a net margin of 2.52% and a return on equity of 20.52%. The company’s revenue for the quarter was down 2.7% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.21 EPS. On average, analysts forecast that Aetna Inc. will post $9.52 EPS for the current fiscal year.
The firm also recently disclosed a quarterly dividend, which was paid on Friday, July 28th. Investors of record on Thursday, July 13th were paid a dividend of $0.50 per share. The ex-dividend date of this dividend was Tuesday, July 11th. This represents a $2.00 annualized dividend and a yield of 1.31%. Aetna’s dividend payout ratio (DPR) is 43.67%.
ILLEGAL ACTIVITY NOTICE: This report was first reported by Daily Political and is the property of of Daily Political. If you are accessing this report on another website, it was copied illegally and reposted in violation of US & international trademark & copyright legislation. The original version of this report can be accessed at https://www.dailypolitical.com/2017/08/13/aetna-inc-aet-shares-sold-by-adirondack-trust-co.html.
AET has been the subject of several recent research reports. Royal Bank Of Canada reaffirmed a “buy” rating and issued a $145.00 price target on shares of Aetna in a report on Monday, April 24th. Bank of America Corporation reiterated a “buy” rating and issued a $168.00 price objective (up from $160.00) on shares of Aetna in a research report on Wednesday, May 17th. Morgan Stanley initiated coverage on Aetna in a research report on Tuesday, June 6th. They issued an “overweight” rating and a $162.00 price objective for the company. Zacks Investment Research upgraded Aetna from a “hold” rating to a “buy” rating and set a $170.00 price objective for the company in a research report on Tuesday, July 4th. Finally, Jefferies Group LLC reiterated a “hold” rating and issued a $163.00 price objective (up from $157.00) on shares of Aetna in a research report on Friday, August 4th. Eight analysts have rated the stock with a hold rating and seventeen have assigned a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $157.09.
In related news, EVP Margaret M. Mccarthy sold 27,028 shares of the stock in a transaction dated Wednesday, June 7th. The shares were sold at an average price of $149.23, for a total transaction of $4,033,388.44. Following the sale, the executive vice president now owns 33,563 shares in the company, valued at $5,008,606.49. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Chairman Mark T. Bertolini sold 103,547 shares of the stock in a transaction dated Wednesday, May 17th. The stock was sold at an average price of $140.79, for a total transaction of $14,578,382.13. Following the sale, the chairman now owns 659,888 shares in the company, valued at approximately $92,905,631.52. The disclosure for this sale can be found here. 0.90% of the stock is owned by corporate insiders.
Aetna Company Profile
Aetna Inc is a diversified healthcare benefits company. The Company operates through three segments: Health Care, Group Insurance and Large Case Pensions. It offers a range of traditional, voluntary and consumer-directed health insurance products and related services, including medical, pharmacy, dental, behavioral health, group life and disability plans, medical management capabilities, Medicaid healthcare management services, Medicare Advantage and Medicare Supplement plans, workers’ compensation administrative services and health information technology (HIT) products and services.
Want to see what other hedge funds are holding AET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Aetna Inc. (NYSE:AET).
Receive News & Ratings for Aetna Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aetna Inc. and related companies with MarketBeat.com's FREE daily email newsletter.